PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden. Joakim.Dillner@sll.se.\', \'Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden.\', \'Karolinska University Hospital, 141 86, Stockholm, Sweden.\', \'Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.\', \'Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Albanova, 144 21, Stockholm, Sweden.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-84356-w
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33664279
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Antibodies to SARS-CoV-2 and risk of past or future sick leave.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33664279>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33664279>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all